A discovery biotransformation strategy: combining in silico tools with high-resolution mass spectrometry and software-assisted data analysis for high-throughput metabolism

References

• Aburjai T, Alzweiri M, Al-Hiari YM. 2011. Temperature and pressure behaviours of methanol, acetonitrile/water mixtures on chromatographic systems. AJAC. 2(8):934–937.
   Google Scholar
• Backfisch G, Reder-Hilz B, Hoeckels-Messemer J, Angstenberger J, Sydor J, Laplanche L, Schulz M. 2015. High-throughput quantitative and qualitative analysis of microsomal incubations by cocktail analysis with an ultraperformance liquid chromatography-quadrupole time-of-flight mass spectrometer system. Bioanalysis. 7(6):671–683.
   PubMed Web of Science ®Google Scholar
• Bonn B, Leandersson C, Fontaine F, Zamora I. 2010. Enhanced metabolite identification with MSE and a semi‐automated software for structural elucidation. Rapid Commun Mass Spectrom. 24(21):3127–3138.
   PubMed Web of Science ®Google Scholar
• Cerny MA, Kalgutkar AS, Obach RS, Sharma R, Spracklin DK, Walker GS. 2020. Effective application of metabolite profiling in drug design and discovery. J Med Chem. 63(12):6387–6406.
   PubMed Web of Science ®Google Scholar
• Colizza K, Mahoney KE, Yevdokimov AV, Smith JL, Oxley JC. 2016. Acetonitrile ion suppression in atmospheric pressure ionization mass spectrometry. J Am Soc Mass Spectrom. 27(11):1796–1804.
   PubMed Web of Science ®Google Scholar
• Cuykens F. 2018. Mass spectrometry in drug metabolism and pharmacokinetics: Current trends and future perspectives. Rapid Commun Mass Spectrom. 33(S3):90–95.
   Web of Science ®Google Scholar
• Dear GJ, Roberts AD, Beaumont C, North SE. 2008. Evaluation of preparative high performance liquid chromatography and cryoprobe-nuclear magnetic resonance spectroscopy for the early quantitative estimation of drug metabolites in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 876(2):182–190.
   PubMed Web of Science ®Google Scholar
• FDA guideline: Safety Testing of Drug Metabolites Guidance for Industry. March 2020. https://www.fda.gov/media/72279/download.
   Google Scholar
• Guo X, Bruins AP, Covey TR. 2006. Characterization of typical chemical background interferences in atmospheric pressure ionization liquid chromatography-mass spectrometry. Rapid Commun Mass Spectrom. 20(20):3145–3150.
   PubMed Web of Science ®Google Scholar
• ICH guideline M3(R2) on non-clinical safety studies for the conduct of human clinical trials and marketing authorisation for pharmaceuticals. Dec 2009. https://www.ema.europa.eu/en/documents/scientific-guideline/ich-guideline-m3r2-non-clinical-safety-studies-conduct-human-clinical-trials-marketing-authorisation_en.pdf
   Google Scholar
• Kalgutkar AS. 2020. Designing around structural alerts in drug discovery. J Med Chem. 63(12):6276–6302.
   PubMed Web of Science ®Google Scholar
• Luippold AH, Arnhold T, Jörg W, Süssmuth RD. 2010. An integrated platform for fully automated high-throughput LC–MS/MS analysis of in vitro metabolic stability assay samples. Int J Mass Spectrom. 296(1–3):1–9.
   Web of Science ®Google Scholar
• Ma S, Chowdhury SK. 2013. Data acquisition and data mining techniques for metabolite identification using LC coupled to high-resolution MS. Bioanalysis. 5(10):1285–1297.
   PubMed Web of Science ®Google Scholar
• McCalley DV. 2010. The challenges of the analysis of basic compounds by high performance liquid chromatography: some possible approaches for improved separations. J Chromatogr A. 1217(6):858–880.
   PubMed Web of Science ®Google Scholar
• Mortishire-Smith RJ, O'Connor D, Castro‐Perez JM, Kirby J. 2005. Accelerated throughput metabolic route screening in early drug discovery using high‐resolution liquid chromatography/quadrupole time‐of‐flight mass spectrometry and automated data analysis. Rapid Commun Mass Spectrom. 19(18):2659–2670.
   PubMed Web of Science ®Google Scholar
• Nassar AE, Kamel AM, Clarimont C. 2004. Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability. Drug Discov Today. 9(23):1020–1028.
   PubMed Web of Science ®Google Scholar
• Nedderman AN, Dear GJ, North S, Obach RS, Higton D. 2011. From definition to implementation: a cross-industry perspective of past, current and future MIST strategies. Xenobiotica. 41(8):605–622.
   PubMed Web of Science ®Google Scholar
• Nguyen S, Fenn JB. 2007. Gas-phase ions of solute species from charged droplets of solutions. Proc Natl Acad Sci USA. 104(4):1111–1117.
   PubMed Web of Science ®Google Scholar
• Pähler A, Brink A. 2013. Software aided approaches to structure-based metabolite identification in drug discovery and development. Drug Discov Today Technol. 10(1):e207–e217.
   PubMedGoogle Scholar
• Paiva A, Shou WZ. 2016. Recent developments in software tools for high-throughput in vitro ADME support with high-resolution MS. Bioanalysis. 8(16):1723–1733.
   PubMed Web of Science ®Google Scholar
• Paiva AA, Klakouski C, Li S, Johnson BM, Shu YZ, Josephs J, Zvyaga T, Zamora I, Shou WZ. 2017. Development, optimization and implementation of a centralized metabolic soft spot assay. Bioanalysis. 9(7):541–552.
   PubMed Web of Science ®Google Scholar
• Parkinson A, Ogilvie BW, Buckley DB, Kazmi F, Parkinson O. 2019. Biotransformation of Xenobiotics. In: Klaassen CD, editor. Casarett & Doull’s toxicology: the basic science of poisons. 9th ed. New York (NY): McGraw-Hill Education.
   Google Scholar
• Ruan Q, Comstock K. 2021. A new workflow for drug metabolite profiling by utilizing advanced tribrid mass spectrometry and data-processing techniques. J Am Soc Mass Spectrom. 32(8):2050–2061.
   PubMed Web of Science ®Google Scholar
• Shah P, Kerns E, Nguyen DT, Obach RS, Wang AQ, Zakharov A, McKew J, Simeonov A, Hop CE, Xu X. 2016. An automated high-throughput metabolic stability assay using an integrated high-resolution accurate mass method and automated data analysis software. Drug Metab Dispos. 44(10):1653–1661.
   PubMed Web of Science ®Google Scholar
• Schadt S, Bister B, Chowdhury SK, Funk C, Hop CECA, Humphreys WG, Igarashi F, James AD, Kagan M, Khojasteh SC, et al. 2018. A decade in the MIST: learnings from investigations of drug metabolites in drug development under the “metabolites in safety testing” regulatory guidance. Drug Metab Dispos. 46(6):865–878.
   PubMed Web of Science ®Google Scholar
• Smith DA, Obach RS, Williams DP, Park BK. 2009. Clearing the MIST (metabolites in safety testing) of time: the impact of duration of administration on drug metabolite toxicity. Chem Biol Interact. 179(1):60–67.
   PubMed Web of Science ®Google Scholar
• Smith DA, Obach RS. 2010. Metabolites: have we MIST out the importance of structure and physicochemistry? Bioanalysis. 2(7):1223–1233.
   PubMed Web of Science ®Google Scholar
• Smith DA, Beaumont K, Maurer TS, Di L. 2019. Clearance in drug design: miniperspective. J Med Chem. 62(5):2245–2255.
   PubMed Web of Science ®Google Scholar
• Srinivasan B. 2021. A guide to the Michaelis-Menten equation: steady state and beyond. FEBS J. 289(20):6086–6098.
   PubMed Web of Science ®Google Scholar
• Tyzack JD, Kirchmair J. 2019. Computational methods and tools to predict cytochrome P450 metabolism for drug discovery. Chem Biol Drug Des. 93(4):377–386.
   PubMed Web of Science ®Google Scholar
• Walles M, Pähler A, Isin EM, Weidolf L. 2022. Meeting report of the second European Biotransformation Workshop. Xenobiotica. 52(4):426–431.
   PubMed Web of Science ®Google Scholar
• Watanabe S, Vikingsson S, Roman M, Green H, Kronstrand R, Wohlfarth A. 2017. In vitro and in vivo metabolite identification studies for the new synthetic opioids acetylfentanyl, acrylfentanyl, furanylfentanyl, and 4-fluoro-isobutyrylfentanyl. AAPS J. 19(4):1102–1122.
   PubMed Web of Science ®Google Scholar
• Wilkinson SD, Martin S, Orton AL, Markandu R, Jones BC. 2020. Drug metabolite identification using ultrahigh‐performance liquid chromatography–ultraviolet spectroscopy and parallelized scans on a tribrid Orbitrap mass spectrometer. Rapid Commun Mass Spectrom. 34(10):8735.
   Web of Science ®Google Scholar
• Zelesky V, Schneider R, Janiszewski J, Zamora I, Ferguson J, Troutman M. 2013. Software automation tools for increased throughput metabolic soft-spot identification in early drug discovery. Bioanalysis. 5(10):1165–1179.
   PubMed Web of Science ®Google Scholar
• Zheng Z, Attygalle AB. 2021. Impact of ambient vapors present in an electrospray ionization source on gas-phase ion structures. J Am Soc Mass Spectrom. 32(3):725–735.
   PubMed Web of Science ®Google Scholar
• Zhu M, Zhang H, Humphreys WG. 2011. Drug metabolite profiling and identification by high-resolution mass spectrometry. J Biol Chem. 286(29):25419–25425.
   PubMed Web of Science ®Google Scholar